JEVTANA |
CABAZITAXEL |
TXD 258 |
CABAZITAXEL ACETONATE |
TXD-258 |
JEVTANA KIT |
XRP 6258 |
XRP-6258 |
TXD258 |
XRP6258 |
CABAZITAXELUM |
JEVANTA® |
TAXOID XRP6258 |
chembl:CHEMBL1201748 |
drugbank:06772 |
pubchem.compound:9854073 |
chemidplus:183133-96-2 |
rxcui:996051 |
FDA Approval | approved |
Drug Class | Small molecule |
Drug Indications | antineoplastic agent |
Drug Class | antineoplastic agent |
Year of Approval | 2010 |
binder |
inhibitor (inhibitory) |
Trial Name | cabazitaxel, XRP6258,Jevtana |
Novel drug target | Established target |
Mechanism of Interaction | Tubulin inhibitor |
binder |
inhibitor (inhibitory) |
Trial Name | cabazitaxel, XRP6258,Jevtana |
Novel drug target | Established target |
Mechanism of Interaction | Tubulin inhibitor |
inhibitor (inhibitory) |
Mechanism of Interaction | Tubulin inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | Tubulin inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Tubulin inhibitor |
inhibitor (inhibitory) |
Mechanism of Interaction | Tubulin inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Tubulin inhibitor |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Tubulin inhibitor |
inhibitor (inhibitory) |
Mechanism of Interaction | Tubulin inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | Tubulin inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Tubulin inhibitor |
inhibitor (inhibitory) |
Mechanism of Interaction | Tubulin inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Tubulin inhibitor |
inhibitor (inhibitory) |
Mechanism of Interaction | Tubulin inhibitor |
Direct Interaction | yes |
CABAZITAXEL | Primary Drug Name |
Year of Approval | 2010 |
Drug Class | antineoplastic agent |
Drug Indications | antineoplastic agent |
Drug Class | Small molecule |
FDA Approval | approved |
D02HSB | TTD Drug ID |